Tissue studies of type IX OI probands will be critical to determine whether the role of CyPB in 3-hydroxylation by the CRTAP/P3H1 complex is fully rescued by redundancy in human cells with total absence of CyPB, but only partially rescued in the presence of truncated CyPB. The gene discussed is P3H1; the disease is osteogenesis imperfecta.